25 XP   0   0   10

Portage Biotech Inc
Buy, Hold or Sell?

Let's analyse Portage Biotech Inc together

PenkeI guess you are interested in Portage Biotech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Portage Biotech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Portage Biotech Inc

I send you an email if I find something interesting about Portage Biotech Inc.

Quick analysis of Portage Biotech Inc (30 sec.)










What can you expect buying and holding a share of Portage Biotech Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.50
Expected worth in 1 year
$-5.51
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$-7.01
Return On Investment
-2,956.8%

For what price can you sell your share?

Current Price per Share
$0.24
Expected price per share
$0.1999 - $0.45
How sure are you?
50%

1. Valuation of Portage Biotech Inc (5 min.)




Live pricePrice per Share (EOD)

$0.24

Intrinsic Value Per Share

$-9.53 - $-4.49

Total Value Per Share

$-8.03 - $-2.99

2. Growth of Portage Biotech Inc (5 min.)




Is Portage Biotech Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$31.3m$169.2m-$106.9m-171.8%

How much money is Portage Biotech Inc making?

Current yearPrevious yearGrowGrow %
Making money-$58.3m-$6.5m-$51.7m-88.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Portage Biotech Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#527 / 1010

Most Revenue
#744 / 1010

Most Profit
#906 / 1010

Most Efficient
#179 / 1010

What can you expect buying and holding a share of Portage Biotech Inc? (5 min.)

Welcome investor! Portage Biotech Inc's management wants to use your money to grow the business. In return you get a share of Portage Biotech Inc.

What can you expect buying and holding a share of Portage Biotech Inc?

First you should know what it really means to hold a share of Portage Biotech Inc. And how you can make/lose money.

Speculation

The Price per Share of Portage Biotech Inc is $0.237. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Portage Biotech Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Portage Biotech Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.50. Based on the TTM, the Book Value Change Per Share is $-1.75 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Portage Biotech Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.88-795.0%-0.69-289.4%-0.22-93.2%-0.26-111.0%0.1876.1%
Usd Book Value Change Per Share-1.89-796.2%-1.75-739.2%-0.04-17.4%0.0522.1%0.0313.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.89-796.2%-1.75-739.2%-0.04-17.4%0.0522.1%0.0313.5%
Usd Price Per Share1.82-2.62-6.41-7.83-3.94-
Price to Earnings Ratio-0.24--1.94--15.86--17.22--8.78-
Price-to-Total Gains Ratio-0.96--2.18--7.10--3.52--2.01-
Price to Book Ratio1.21-0.89-0.75-1.10-0.60-
Price-to-Total Gains Ratio-0.96--2.18--7.10--3.52--2.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.237
Number of shares4219
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.750.05
Usd Total Gains Per Share-1.750.05
Gains per Quarter (4219 shares)-7,391.21220.63
Gains per Year (4219 shares)-29,564.83882.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-29565-295750883873
20-59130-59140017651756
30-88694-88705026482639
40-118259-118270035303522
50-147824-147835044134405
60-177389-177400052955288
70-206954-206965061786171
80-236519-236530070607054
90-266083-266095079437937
100-295648-295660088258820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%3.037.00.07.5%8.084.00.08.7%
Book Value Change Per Share0.03.01.00.0%2.07.03.016.7%6.010.04.030.0%14.018.08.035.0%39.039.014.042.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.092.00.0%
Total Gains per Share0.03.01.00.0%2.07.03.016.7%6.010.04.030.0%14.018.08.035.0%39.039.014.042.4%

Fundamentals of Portage Biotech Inc

About Portage Biotech Inc

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline includes PORT-2 for treatment of refractory NSCLC, melanoma, and refractory melanoma that is in phase I and phase II clinical trials; PORT-3, for treatment of solid tumors, which is in phase I clinical trials; PORT-6, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ia clinical trials; PORT-7, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ib clinical trials; PORT-1, an intratumoral amphiphilic solutions for treatment of advanced soft tissue sarcoma, which is in phase 3 clinical trials; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors that is in preclinical trials. The company is based in Tortola, British Virgin Islands.

Fundamental data was last updated by Penke on 2024-04-12 15:47:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Portage Biotech Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Portage Biotech Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Portage Biotech Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Portage Biotech Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.3%+282.3%
5Y--436.8%+436.8%
10Y--597.3%+597.3%
1.1.2. Return on Assets

Shows how efficient Portage Biotech Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Portage Biotech Inc to the Biotechnology industry mean.
  • -77.8% Return on Assets means that Portage Biotech Inc generated $-0.78 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Portage Biotech Inc:

  • The MRQ is -77.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -68.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-77.8%TTM-68.5%-9.3%
TTM-68.5%YOY-3.3%-65.2%
TTM-68.5%5Y-15.5%-53.0%
5Y-15.5%10Y50.8%-66.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-77.8%-13.3%-64.5%
TTM-68.5%-12.8%-55.7%
YOY-3.3%-11.6%+8.3%
5Y-15.5%-13.8%-1.7%
10Y50.8%-15.6%+66.4%
1.1.3. Return on Equity

Shows how efficient Portage Biotech Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Portage Biotech Inc to the Biotechnology industry mean.
  • -123.0% Return on Equity means Portage Biotech Inc generated $-1.23 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Portage Biotech Inc:

  • The MRQ is -123.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -94.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-123.0%TTM-94.8%-28.3%
TTM-94.8%YOY-4.9%-89.8%
TTM-94.8%5Y-21.9%-72.8%
5Y-21.9%10Y46.3%-68.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-123.0%-16.9%-106.1%
TTM-94.8%-16.1%-78.7%
YOY-4.9%-14.9%+10.0%
5Y-21.9%-19.3%-2.6%
10Y46.3%-20.1%+66.4%

1.2. Operating Efficiency of Portage Biotech Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Portage Biotech Inc is operating .

  • Measures how much profit Portage Biotech Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Portage Biotech Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Portage Biotech Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY--288.4%+288.4%
5Y--486.2%+486.2%
10Y--628.4%+628.4%
1.2.2. Operating Ratio

Measures how efficient Portage Biotech Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Portage Biotech Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-3.310-3.310
YOY-3.838-3.838
5Y-5.679-5.679
10Y-7.823-7.823

1.3. Liquidity of Portage Biotech Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Portage Biotech Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.78 means the company has $2.78 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Portage Biotech Inc:

  • The MRQ is 2.775. The company is able to pay all its short-term debts. +1
  • The TTM is 4.860. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.775TTM4.860-2.084
TTM4.860YOY20.456-15.596
TTM4.8605Y9.319-4.459
5Y9.31910Y77.471-68.152
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7753.863-1.088
TTM4.8604.169+0.691
YOY20.4565.337+15.119
5Y9.3196.122+3.197
10Y77.4716.434+71.037
1.3.2. Quick Ratio

Measures if Portage Biotech Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Portage Biotech Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.99 means the company can pay off $1.99 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Portage Biotech Inc:

  • The MRQ is 1.993. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.821. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.993TTM3.821-1.828
TTM3.821YOY19.253-15.432
TTM3.8215Y8.733-4.912
5Y8.73310Y140.264-131.531
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9933.504-1.511
TTM3.8213.991-0.170
YOY19.2535.371+13.882
5Y8.7336.088+2.645
10Y140.2646.395+133.869

1.4. Solvency of Portage Biotech Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Portage Biotech Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Portage Biotech Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.38 means that Portage Biotech Inc assets are financed with 38.1% credit (debt) and the remaining percentage (100% - 38.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Portage Biotech Inc:

  • The MRQ is 0.381. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.284. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.381TTM0.284+0.097
TTM0.284YOY0.170+0.114
TTM0.2845Y0.178+0.106
5Y0.17810Y0.113+0.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3810.339+0.042
TTM0.2840.337-0.053
YOY0.1700.271-0.101
5Y0.1780.368-0.190
10Y0.1130.388-0.275
1.4.2. Debt to Equity Ratio

Measures if Portage Biotech Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Portage Biotech Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 60.2% means that company has $0.60 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Portage Biotech Inc:

  • The MRQ is 0.602. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.400. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.602TTM0.400+0.201
TTM0.400YOY0.238+0.163
TTM0.4005Y0.277+0.123
5Y0.27710Y0.185+0.093
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6020.392+0.210
TTM0.4000.403-0.003
YOY0.2380.335-0.097
5Y0.2770.427-0.150
10Y0.1850.461-0.276

2. Market Valuation of Portage Biotech Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Portage Biotech Inc generates.

  • Above 15 is considered overpriced but always compare Portage Biotech Inc to the Biotechnology industry mean.
  • A PE ratio of -0.24 means the investor is paying $-0.24 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Portage Biotech Inc:

  • The EOD is -0.031. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.241. Based on the earnings, the company is expensive. -2
  • The TTM is -1.937. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.031MRQ-0.241+0.210
MRQ-0.241TTM-1.937+1.696
TTM-1.937YOY-15.862+13.925
TTM-1.9375Y-17.218+15.281
5Y-17.21810Y-8.783-8.435
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.031-2.300+2.269
MRQ-0.241-2.656+2.415
TTM-1.937-2.718+0.781
YOY-15.862-4.145-11.717
5Y-17.218-6.258-10.960
10Y-8.783-6.315-2.468
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Portage Biotech Inc:

  • The EOD is -0.371. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.852. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.054. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.371MRQ-2.852+2.480
MRQ-2.852TTM-3.054+0.202
TTM-3.054YOY-13.215+10.161
TTM-3.0545Y-32.625+29.571
5Y-32.62510Y-16.710-15.915
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.371-2.974+2.603
MRQ-2.852-3.306+0.454
TTM-3.054-3.508+0.454
YOY-13.215-5.613-7.602
5Y-32.625-8.378-24.247
10Y-16.710-8.873-7.837
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Portage Biotech Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.21 means the investor is paying $1.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Portage Biotech Inc:

  • The EOD is 0.158. Based on the equity, the company is cheap. +2
  • The MRQ is 1.214. Based on the equity, the company is underpriced. +1
  • The TTM is 0.890. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.158MRQ1.214-1.056
MRQ1.214TTM0.890+0.324
TTM0.890YOY0.750+0.140
TTM0.8905Y1.101-0.211
5Y1.10110Y0.596+0.505
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.1581.914-1.756
MRQ1.2142.116-0.902
TTM0.8902.097-1.207
YOY0.7502.881-2.131
5Y1.1013.550-2.449
10Y0.5963.936-3.340
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Portage Biotech Inc.

3.1. Institutions holding Portage Biotech Inc

Institutions are holding 11.62% of the shares of Portage Biotech Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Armistice Capital, LLC9.48280.04661876105-92000-4.6745
2023-12-31Lakeview Capital Partners, LLC1.07860.068821339800
2023-12-31PEAK6 INVESTMENTS LP0.25890.000451221512210
2023-12-31BlackRock Inc0.178103524031189.7067
2023-12-31Renaissance Technologies Corp0.10660.000121100710050.7143
2023-12-31BEACON INVESTMENT ADVISORY SERVICES, INC.0.05760.000911395113950
2023-12-31IEQ CAPITAL, LLC0.05690.000311250-5400-32.4324
2023-12-31Dimensional Fund Advisors, Inc.0.0534010565-3789-26.3968
2023-12-31Pathstone Holdings LLC0.05110.000110100101000
2023-09-30ADVISOR PARTNERS II, LLC0.05110.00091010000
2023-12-31Barclays PLC0.026505243-412-7.2856
2023-12-31Royal Bank of Canada0.008201627-1407-46.3744
2023-12-31Morgan Stanley - Brokerage Accounts0.008101598-1073-40.1722
2023-12-31Crédit Agricole S.A.0.00680135000
2023-12-31Wells Fargo & Co0.0035070000
2023-12-31SIMPLEX TRADING, LLC0.001803503500
2023-12-31CWM, LLC duplicate0.0011021500
2023-12-31Princeton Global Asset Management LLC0.00080.000115000
2023-12-31UBS Group AG0.0005010000
2023-12-31The Toronto-Dominion Bank007-7-50
Total 11.43240.11822261814-20804-0.9%

3.2. Funds holding Portage Biotech Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28iShares Micro-Cap ETF0.10870.00132150800
2024-02-29Fidelity Nasdaq Composite Index0.04590908100
2024-02-291290 VT Micro Cap K0.00790.0006156200
2023-11-30Guggenheim Active Allocation Fund0.000102900
Total 0.16260.00193218000.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Portage Biotech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.887-1.752-7%-0.041-98%0.052-3709%0.032-5977%
Book Value Per Share--1.4993.127-52%8.554-82%6.949-78%4.384-66%
Current Ratio--2.7754.860-43%20.456-86%9.319-70%77.471-96%
Debt To Asset Ratio--0.3810.284+34%0.170+124%0.178+114%0.113+236%
Debt To Equity Ratio--0.6020.400+50%0.238+153%0.277+117%0.185+226%
Dividend Per Share----0%-0%-0%-0%
Eps---1.884-0.686-64%-0.221-88%-0.263-86%0.180-1145%
Free Cash Flow Per Share---0.160-0.212+33%-0.123-23%-0.096-40%-0.058-64%
Free Cash Flow To Equity Per Share--0.093-0.095+202%-0.227+344%-0.102+209%-0.046+150%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.494--------
Intrinsic Value_10Y_min---9.529--------
Intrinsic Value_1Y_max---0.264--------
Intrinsic Value_1Y_min---0.604--------
Intrinsic Value_3Y_max---0.934--------
Intrinsic Value_3Y_min---2.129--------
Intrinsic Value_5Y_max---1.777--------
Intrinsic Value_5Y_min---3.988--------
Market Cap4688902.800-711%38032540.00052415552.500-27%126912474.510-70%154960274.252-75%77997548.647-51%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.158-668%1.2140.890+36%0.750+62%1.101+10%0.596+104%
Pe Ratio-0.031+87%-0.241-1.937+702%-15.862+6469%-17.218+7030%-8.783+3537%
Price Per Share0.237-668%1.8202.624-31%6.415-72%7.827-77%3.940-54%
Price To Free Cash Flow Ratio-0.371+87%-2.852-3.054+7%-13.215+363%-32.625+1044%-16.710+486%
Price To Total Gains Ratio-0.126+87%-0.964-2.182+126%-7.103+636%-3.519+265%-2.006+108%
Quick Ratio--1.9933.821-48%19.253-90%8.733-77%140.264-99%
Return On Assets---0.778-0.685-12%-0.033-96%-0.155-80%0.508-253%
Return On Equity---1.230-0.948-23%-0.049-96%-0.219-82%0.463-366%
Total Gains Per Share---1.887-1.752-7%-0.041-98%0.052-3709%0.032-5977%
Usd Book Value--31330000.00062279250.000-50%169244250.000-81%137564250.000-77%86780045.925-64%
Usd Book Value Change Per Share---1.887-1.752-7%-0.041-98%0.052-3709%0.032-5977%
Usd Book Value Per Share--1.4993.127-52%8.554-82%6.949-78%4.384-66%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.884-0.686-64%-0.221-88%-0.263-86%0.180-1145%
Usd Free Cash Flow---3334058.000-4248311.625+27%-2430222.833-27%-1911856.892-43%-1149867.421-66%
Usd Free Cash Flow Per Share---0.160-0.212+33%-0.123-23%-0.096-40%-0.058-64%
Usd Free Cash Flow To Equity Per Share--0.093-0.095+202%-0.227+344%-0.102+209%-0.046+150%
Usd Market Cap4688902.800-711%38032540.00052415552.500-27%126912474.510-70%154960274.252-75%77997548.647-51%
Usd Price Per Share0.237-668%1.8202.624-31%6.415-72%7.827-77%3.940-54%
Usd Profit---39373000.000-58356750.000+48%-6578000.000-83%-15056550.000-62%-1359135.675-97%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---1.887-1.752-7%-0.041-98%0.052-3709%0.032-5977%
 EOD+3 -5MRQTTM+8 -21YOY+4 -255Y+4 -2510Y+4 -26

4.2. Fundamental Score

Let's check the fundamental score of Portage Biotech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.031
Price to Book Ratio (EOD)Between0-10.158
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.993
Current Ratio (MRQ)Greater than12.775
Debt to Asset Ratio (MRQ)Less than10.381
Debt to Equity Ratio (MRQ)Less than10.602
Return on Equity (MRQ)Greater than0.15-1.230
Return on Assets (MRQ)Greater than0.05-0.778
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Portage Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.889
Ma 20Greater thanMa 500.402
Ma 50Greater thanMa 1000.495
Ma 100Greater thanMa 2000.796
OpenGreater thanClose0.259
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -3,059-1,266-4,3250-4,325469-3,85626,42722,571



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets50,584
Total Liabilities19,254
Total Stockholder Equity31,999
 As reported
Total Liabilities 19,254
Total Stockholder Equity+ 31,999
Total Assets = 50,584

Assets

Total Assets50,584
Total Current Assets7,516
Long-term Assets43,068
Total Current Assets
Cash And Cash Equivalents 5,341
Net Receivables 56
Other Current Assets 2,119
Total Current Assets  (as reported)7,516
Total Current Assets  (calculated)7,516
+/-0
Long-term Assets
Property Plant Equipment 263
Long Term Investments 5,996
Intangible Assets 34,761
Long-term Assets Other 499
Long-term Assets  (as reported)43,068
Long-term Assets  (calculated)41,519
+/- 1,549

Liabilities & Shareholders' Equity

Total Current Liabilities2,708
Long-term Liabilities16,546
Total Stockholder Equity31,999
Total Current Liabilities
Short-term Debt 50
Other Current Liabilities 2,658
Total Current Liabilities  (as reported)2,708
Total Current Liabilities  (calculated)2,708
+/-0
Long-term Liabilities
Capital Lease Obligations 275
Long-term Liabilities  (as reported)16,546
Long-term Liabilities  (calculated)275
+/- 16,271
Total Stockholder Equity
Common Stock219,494
Retained Earnings -210,066
Accumulated Other Comprehensive Income 22,571
Total Stockholder Equity (as reported)31,999
Total Stockholder Equity (calculated)31,999
+/-0
Other
Capital Stock219,494
Cash and Short Term Investments 5,341
Common Stock Shares Outstanding 20,897
Liabilities and Stockholders Equity 50,584
Net Debt -5,066
Net Invested Capital 31,999
Net Working Capital 4,808
Property Plant and Equipment Gross 263
Short Long Term Debt Total 275



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-31
> Total Assets 
1,056
577
577
599
169
130
130
94
30
20
448
1,381
1,750
2,353
2,118
2,111
2,448
4,195
3,428
2,353
2,816
4,676
5,512
5,429
5,166
5,784
6,551
6,541
5,793
5,090
5,090
3,034
1,488
1,262
1,262
1,547
22,356
10,221
10,221
9,882
10,430
9,622
9,622
7,301
5,959
7,514
6,912
4,010
6,912
3,431
3,766
3,348
4,345
5,263
4,674
4,383
5,745
4,736
4,736
8,978
9,379
12,629
12,629
45,724
39,771
59,904
59,904
238,069
173,972
10,003
10,003
9,521
9,367
173,715
172,825
173,715
173,495
173,174
173,174
175,718
174,886
174,860
174,860
198,437
195,806
194,662
194,662
216,525
210,683
99,129
99,129
92,400
50,584
50,58492,40099,12999,129210,683216,525194,662194,662195,806198,437174,860174,860174,886175,718173,174173,174173,495173,715172,825173,7159,3679,52110,00310,003173,972238,06959,90459,90439,77145,72412,62912,6299,3798,9784,7364,7365,7454,3834,6745,2634,3453,3483,7663,4316,9124,0106,9127,5145,9597,3019,6229,62210,4309,88210,22110,22122,3561,5471,2621,2621,4883,0345,0905,0905,7936,5416,5515,7845,1665,4295,5124,6762,8162,3533,4284,1952,4482,1112,1182,3531,7501,3814482030941301301695995775771,056
   > Total Current Assets 
626
429
429
298
59
43
43
7
30
20
448
42
12
423
219
355
480
4,016
3,110
423
2,816
4,676
5,512
5,429
5,166
5,784
6,551
6,539
5,790
5,084
5,084
3,024
1,479
1,254
1,254
1,540
2,416
3,817
3,817
2,746
3,234
2,439
2,439
574
5,952
7,507
6,906
4,004
6,906
3,425
3,761
3,343
4,341
2,259
1,670
1,379
2,741
1,736
1,736
3,998
3,136
4,893
4,893
519
299
59,136
59,136
237,301
173,216
7,616
7,616
7,236
6,196
6,551
5,704
6,551
3,548
3,794
3,794
4,911
4,200
4,946
4,946
28,645
26,275
24,832
24,832
17,170
15,532
13,676
13,676
6,267
7,516
7,5166,26713,67613,67615,53217,17024,83224,83226,27528,6454,9464,9464,2004,9113,7943,7943,5486,5515,7046,5516,1967,2367,6167,616173,216237,30159,13659,1362995194,8934,8933,1363,9981,7361,7362,7411,3791,6702,2594,3413,3433,7613,4256,9064,0046,9067,5075,9525742,4392,4393,2342,7463,8173,8172,4161,5401,2541,2541,4793,0245,0845,0845,7906,5396,5515,7845,1665,4295,5124,6762,8164233,1104,016480355219423124244820307434359298429429626
       Cash And Cash Equivalents 
16
26
26
3
1
30
30
0
0
14
441
35
1
382
155
21
255
711
466
382
1,191
2,799
2,699
2,186
1,848
2,613
2,580
2,224
1,600
1,223
1,223
513
370
280
280
224
400
2,306
2,306
341
275
359
359
63
151
58
124
2,243
124
3,319
3,698
3,283
3,060
2,032
1,650
1,370
2,726
1,718
1,718
3,566
2,937
4,689
4,689
468
252
159
159
197
2,073
7,520
7,520
7,098
6,044
6,166
5,187
6,166
2,994
3,152
3,152
4,431
3,637
2,770
2,770
27,261
25,603
23,352
23,352
15,038
13,104
10,545
10,545
3,445
5,341
5,3413,44510,54510,54513,10415,03823,35223,35225,60327,2612,7702,7703,6374,4313,1523,1522,9946,1665,1876,1666,0447,0987,5207,5202,0731971591592524684,6894,6892,9373,5661,7181,7182,7261,3701,6502,0323,0603,2833,6983,3191242,24312458151633593592753412,3062,3064002242802803705131,2231,2231,6002,2242,5802,6131,8482,1862,6992,7991,191382466711255211553821354411400303013262616
       Short-term Investments 
206
24
24
20
20
0
0
0
0
0
0
0
0
0
0
283
189
63
69
593
1,137
1,525
2,544
3,076
3,227
2,874
3,716
4,167
4,100
3,530
3,530
2,333
979
864
864
1,222
1,896
1,334
1,334
1,678
2,714
1,955
1,955
459
232
228
84
67
84
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,913
58,913
237,046
171,094
52
52
75
74
103
88
103
109
68
68
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000068681091038810374755252171,094237,04658,91358,91300000000000000008467842282324591,9551,9552,7141,6781,3341,3341,8961,2228648649792,3333,5303,5304,1004,1673,7162,8743,2273,0762,5441,5251,1375936963189283000000000020202424206
       Net Receivables 
340
371
371
241
15
13
13
6
30
6
8
7
11
36
46
46
35
22
425
36
0
0
0
0
0
0
0
0
0
53
53
61
95
94
94
93
120
127
127
679
217
117
117
53
199
232
5,220
1,693
5,220
107
63
60
26
0
0
0
0
0
0
0
0
0
0
0
0
16
16
20
19
28
28
58
77
55
57
55
60
60
60
451
556
683
683
749
324
209
209
838
826
682
682
481
56
5648168268282683820920932474968368355645160606055575577582828192016160000000000002660631075,2201,6935,220232199531171172176791271271209394949561535300000000036425223546463611786306131315241371371340
       Other Current Assets 
65
0
0
34
23
0
0
0
0
0
0
0
0
6
0
0
-4
3,220
2,150
6
81
270
182
109
35
239
186
120
41
0
0
0
35
16
16
0
0
50
50
48
29
7
7
0
5,369
6,989
1,479
0
1,468
0
0
0
1,254
227
20
9
15
18
18
433
199
204
204
51
46
48
48
38
30
16
16
5
1
227
372
227
385
514
514
480
7
1,493
1,493
635
672
1,271
1,271
1,294
1,602
119
2,449
2,341
2,119
2,1192,3412,4491191,6021,2941,2711,2716726351,4931,49374805145143852273722271516163038484846512042041994331818159202271,2540001,46801,4796,9895,369077294850500016163500041120186239351091822708162,1503,220-40060000000023340065
   > Long-term Assets 
430
148
148
301
110
87
87
87
0
0
0
1,339
1,738
1,930
1,899
1,756
1,969
179
317
1,930
0
0
0
0
0
0
0
2
2
6
6
10
8
7
7
8
19,940
6,405
6,405
7,136
7,196
7,183
7,183
6,727
7
7
6
6
6
6
5
5
5
3,004
3,004
3,004
3,003
3,000
3,000
4,980
6,243
7,736
7,736
45,205
39,472
768
768
768
756
2,387
2,387
2,285
3,171
167,164
167,121
167,164
169,947
169,380
169,380
170,807
170,686
169,914
169,914
169,792
169,531
169,830
169,830
199,355
195,151
85,453
85,453
86,133
43,068
43,06886,13385,45385,453195,151199,355169,830169,830169,531169,792169,914169,914170,686170,807169,380169,380169,947167,164167,121167,1643,1712,2852,3872,38775676876876839,47245,2057,7367,7366,2434,9803,0003,0003,0033,0043,0043,0045556666776,7277,1837,1837,1967,1366,4056,40519,940877810662200000001,9303171791,9691,7561,8991,9301,7381,339000878787110301148148430
       Property Plant Equipment 
31
26
26
18
13
0
0
0
0
0
0
0
0
0
1
42
1,969
179
317
0
0
0
0
0
0
0
0
2
2
6
6
10
8
7
7
8
9
6,405
6,405
7,136
7,196
7,183
7,183
6,727
7
7
6
6
6
6
5
5
5
4
4
4
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2,631
278
263
263278-2,63100000000000000000000000000000000034445556666776,7277,1837,1837,1967,1366,4056,40598778106622000000003171791,9694210000000001318262631
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,070
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,000
3,000
3,000
3,000
3,000
3,000
0
0
0
0
0
0
0
0
0
0
43,324
43,324
43,324
43,324
43,324
43,324
43,324
43,324
43,324
43,324
43,324
43,324
43,324
43,324
43,464
43,862
0
0
0
0
000043,86243,46443,32443,32443,32443,32443,32443,32443,32443,32443,32443,32443,32443,32443,32443,32400000000003,0003,0003,0003,0003,0003,000000000000000000000003,070000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,190
8,634
10,074
10,025
9,904
9,144
9,100
9,042
8,781
9,082
9,022
8,966
4,768
2,893
4,611
3,284
5,996
5,9963,2844,6112,8934,7688,9669,0229,0828,7819,0429,1009,1449,90410,02510,0748,6349,1900000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,000
3,000
0
3,000
0
0
1,280
2,543
4,036
4,036
0
0
0
0
0
0
0
0
0
0
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
145,986
145,588
81,683
81,683
81,683
34,761
34,76181,68381,68381,683145,588145,986117,388117,388117,388117,388117,388117,388117,388117,388117,388117,388117,388117,388117,388117,38800000000004,0364,0362,5431,280003,00003,0003,00000000000000000000000000000000000000000000000000000000
       Long-term Assets Other 
399
122
122
283
97
87
87
0
0
0
0
1,339
1,738
1,930
1,898
1,714
0
0
0
1,930
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,861
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,000
0
0
0
0
0
0
0
0
79
68
68
68
56
1,006
1,006
1,006
1,945
45
45
45
45
34
34
70
70
58
58
38
38
36
36
939
933
877
877
49
499
4994987787793393936363838585870703434454545451,9451,0061,0061,0065668686879000000003,00000000000000000000016,86100000000000000001,9300001,7141,8981,9301,7381,3390000878797283122122399
> Total Liabilities 
130
95
95
73
132
126
126
188
210
234
269
462
551
661
157
235
173
103
71
661
93
142
42
46
16
42
63
40
43
57
57
35
87
120
120
77
15,853
3,453
3,453
1,815
2,068
683
683
715
1,014
2,662
1,298
328
1,298
447
170
100
94
192
496
583
1,016
621
621
176
81
300
300
77
131
309
309
427
2,375
384
384
293
397
25,158
25,464
25,158
25,593
27,533
27,533
26,490
22,929
27,258
27,258
24,858
24,242
29,228
29,228
38,718
42,381
23,734
23,734
25,403
19,254
19,25425,40323,73423,73442,38138,71829,22829,22824,24224,85827,25827,25822,92926,49027,53327,53325,59325,15825,46425,1583972933843842,37542730930913177300300811766216211,016583496192941001704471,2983281,2982,6621,0147156836832,0681,8153,4533,45315,8537712012087355757434063421646421429366171103173235157661551462269234210188126126132739595130
   > Total Current Liabilities 
130
95
95
73
132
126
126
188
210
234
269
462
551
661
157
235
173
103
71
661
93
142
42
46
16
42
63
40
43
57
57
35
87
120
120
77
12,832
3,453
3,453
1,815
2,068
683
683
715
1,014
2,662
1,298
328
1,298
447
170
100
94
192
496
583
1,016
621
621
176
81
300
300
77
131
109
109
173
2,119
127
127
79
181
1,794
2,100
1,794
1,571
2,568
2,568
4,886
1,325
3,208
3,208
1,344
636
783
783
1,433
2,422
1,865
1,865
3,136
2,708
2,7083,1361,8651,8652,4221,4337837836361,3443,2083,2081,3254,8862,5682,5681,5711,7942,1001,794181791271272,11917310910913177300300811766216211,016583496192941001704471,2983281,2982,6621,0147156836832,0681,8153,4533,45312,8327712012087355757434063421646421429366171103173235157661551462269234210188126126132739595130
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,685
1,045
1,045
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2,051
0
0
0
0
663
665
663
298
300
300
300
300
150
150
0
0
0
0
0
0
0
47
49
50
50494700000001501503003003003002986636656630000-2,051000000000000000000000000000001,0451,0451,685000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
298
300
300
300
300
150
150
0
0
0
0
0
0
0
0
0
0
00000000001501503003003003002980000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
33
41
41
20
38
41
41
40
40
47
65
151
168
267
103
178
114
91
57
267
79
26
39
43
13
17
33
27
24
29
29
22
71
76
76
57
10,949
1,383
1,383
1,450
1,840
520
520
0
0
0
0
0
125
447
170
100
94
192
496
583
1,016
621
621
176
81
300
300
77
131
109
109
173
68
127
127
79
181
388
1,411
388
429
343
343
343
254
1,938
1,938
809
477
188
188
1,425
2,422
274
274
3,087
0
03,0872742742,4221,4251881884778091,9381,9382543433433434293881,411388181791271276817310910913177300300811766216211,01658349619294100170447125000005205201,8401,4501,3831,38310,9495776767122292924273317134339267926757911141781032671681516547404041413820414133
       Other Current Liabilities 
97
54
54
53
94
85
85
148
169
187
204
311
383
393
54
57
59
12
14
393
14
115
3
3
3
25
29
13
19
28
28
13
16
44
44
20
199
1,024
1,024
365
228
163
163
715
1,014
2,662
1,298
328
1,298
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,051
0
0
0
0
24
24
24
24
1,925
1,925
271
771
1,120
1,120
1,344
159
595
595
8
0
1,591
1,591
3,087
2,658
2,6583,0871,5911,591085955951591,3441,1201,1207712711,9251,9252424242400002,05100000000000000000001,2983281,2982,6621,0147151631632283651,0241,024199204444161328281913292533311514393141259575439338331120418716914885859453545497
   > Long-term Liabilities 
0
41
41
0
0
41
41
40
0
47
0
151
168
267
103
0
114
0
57
267
79
26
0
0
13
0
33
27
0
29
29
0
71
76
76
57
3,021
2,429
2,429
1,450
1,840
520
520
0
0
0
0
0
125
447
170
100
94
192
0
583
1,016
621
621
176
81
300
300
77
131
200
200
254
256
257
257
214
216
23,364
23,364
23,364
24,022
24,965
24,965
21,604
21,604
24,050
24,050
23,514
23,606
28,445
28,445
37,285
39,959
21,869
21,869
22,267
16,546
16,54622,26721,86921,86939,95937,28528,44528,44523,60623,51424,05024,05021,60421,60424,96524,96524,02223,36423,36423,36421621425725725625420020013177300300811766216211,016583019294100170447125000005205201,8401,4502,4292,4293,021577676710292902733013002679267570114010326716815104704041410041410
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,604
21,604
21,604
21,604
24,050
24,171
23,514
23,606
28,445
25,893
37,285
39,959
0
22,832
0
0
0022,832039,95937,28525,89328,44523,60623,51424,17124,05021,60421,60421,60421,60400000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
117,388
146,886
146,482
0
82,522
0
0
0082,5220146,482146,886117,388117,388117,388117,388117,388117,388117,388117,388117,388117,38800000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
925
482
482
526
37
3
3
-94
-180
-214
179
919
1,199
1,693
1,962
1,876
2,275
4,093
3,357
1,693
2,723
4,534
5,470
5,383
5,150
5,742
6,488
6,502
5,750
5,033
5,033
2,999
1,401
1,141
1,141
1,470
6,503
7,119
7,119
8,536
8,976
8,939
8,939
6,586
4,945
4,852
5,614
3,682
5,614
2,984
3,596
3,248
4,251
2,393
1,747
1,615
2,795
2,660
2,660
6,230
8,052
10,269
10,269
45,647
39,640
59,594
59,594
237,642
171,597
9,619
9,619
9,229
8,979
99,674
98,222
99,674
98,574
96,531
96,531
102,233
104,945
101,449
101,449
127,140
125,789
121,205
121,205
178,434
168,945
76,045
76,045
67,661
31,999
31,99967,66176,04576,045168,945178,434121,205121,205125,789127,140101,449101,449104,945102,23396,53196,53198,57499,67498,22299,6748,9799,2299,6199,619171,597237,64259,59459,59439,64045,64710,26910,2698,0526,2302,6602,6602,7951,6151,7472,3934,2513,2483,5962,9845,6143,6825,6144,8524,9456,5868,9398,9398,9768,5367,1197,1196,5031,4701,1411,1411,4012,9995,0335,0335,7506,5026,4885,7425,1505,3835,4704,5342,7231,6933,3574,0932,2751,8761,9621,6931,199919179-214-180-943337526482482925
   Common Stock
13,193
12,573
12,573
12,710
12,600
12,786
12,786
12,850
12,954
13,894
15,580
16,357
17,346
18,523
18,785
19,894
21,347
23,378
23,537
18,523
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,064
0
0
0
0
0
0
0
36,395
35,639
6,516
6,516
7,207
7,257
7,257
7,777
9,572
9,692
9,692
14,847
14,847
17,055
17,055
17,055
17,055
18,360
18,360
19,158
19,432
23,654
23,654
23,654
23,654
116,237
116,237
116,237
117,535
117,817
117,817
126,670
130,588
130,649
130,649
158,216
158,294
158,324
158,324
215,830
216,630
218,782
218,782
219,494
219,494
219,494219,494218,782218,782216,630215,830158,324158,324158,294158,216130,649130,649130,588126,670117,817117,817117,535116,237116,237116,23723,65423,65423,65423,65419,43219,15818,36018,36017,05517,05517,05517,05514,84714,8479,6929,6929,5727,7777,2577,2577,2076,5166,51635,63936,395000000036,0640000000000000000000018,52323,53723,37821,34719,89418,78518,52317,34616,35715,58013,89412,95412,85012,78612,78612,60012,71012,57312,57313,193
   Retained Earnings 
-12,267
-12,091
-12,091
-12,184
-12,563
-12,783
-12,783
-12,944
-13,133
-14,108
-15,401
-15,438
-16,147
-16,831
-16,824
-18,019
-19,072
-22,423
-23,278
-16,831
-27,397
-27,372
-28,979
-28,999
-27,782
-27,803
-30,292
-32,735
-32,990
-31,717
-31,717
-30,978
-27,172
-26,400
-26,400
-32,093
-33,363
-36,553
-36,553
-37,873
-40,136
-42,176
-42,176
-40,992
-42,071
-43,561
-41,849
-45,452
-41,849
-44,162
-4,028
-4,376
-4,668
-6,334
-7,120
-7,849
-8,486
-9,453
-9,453
-11,259
-14,014
-14,618
-14,618
27,058
20,984
14,981
14,981
14,307
13,955
-14,334
-14,334
-14,761
-15,045
-16,969
-18,411
-16,969
-21,000
-22,302
-22,302
-25,453
-26,637
-38,135
-38,135
-44,176
-47,688
-55,005
-55,005
-57,683
-65,168
-159,616
-159,616
-170,693
-210,066
-210,066-170,693-159,616-159,616-65,168-57,683-55,005-55,005-47,688-44,176-38,135-38,135-26,637-25,453-22,302-22,302-21,000-16,969-18,411-16,969-15,045-14,761-14,334-14,33413,95514,30714,98114,98120,98427,058-14,618-14,618-14,014-11,259-9,453-9,453-8,486-7,849-7,120-6,334-4,668-4,376-4,028-44,162-41,849-45,452-41,849-43,561-42,071-40,992-42,176-42,176-40,136-37,873-36,553-36,553-33,363-32,093-26,400-26,400-27,172-30,978-31,717-31,717-32,990-32,735-30,292-27,803-27,782-28,999-28,979-27,372-27,397-16,831-23,278-22,423-19,072-18,019-16,824-16,831-16,147-15,438-15,401-14,108-13,133-12,944-12,783-12,783-12,563-12,184-12,091-12,091-12,267
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,120
31,906
34,449
28,148
26,959
27,512
29,918
32,079
36,952
38,019
38,019
36,967
32,142
31,046
31,046
36,687
42,044
46,317
46,317
47,947
13,435
50,942
50,942
47,712
47,208
48,413
47,471
49,136
47,471
11,508
1,108
1,108
1,108
1,108
1,108
1,687
1,709
1,108
1,108
2,642
7,219
2,756
2,756
0
45,647
1,705
1,705
1,497
1,482
267
267
280
316
324
329
324
340
58
58
58
36
7,977
7,977
12,142
14,225
16,928
16,928
19,329
20,542
21,204
21,204
22,716
0
022,71621,20421,20420,54219,32916,92816,92814,22512,1427,9777,977365858583403243293243162802672671,4821,4971,7051,70545,64702,7562,7567,2192,6421,1081,1081,7091,6871,1081,1081,1081,1081,10811,50847,47149,13647,47148,41347,20847,71250,94250,94213,43547,94746,31746,31742,04436,68731,04631,04632,14236,96738,01938,01936,95232,07929,91827,51226,95928,14834,44931,90630,12000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1
Gross Profit-1-1
 
Operating Income (+$)
Gross Profit-1
Operating Expense-16,576
Operating Income-16,575-16,577
 
Operating Expense (+$)
Research Development8,214
Selling General Administrative8,361
Selling And Marketing Expenses0
Operating Expense16,57616,575
 
Net Interest Income (+$)
Interest Income217
Interest Expense-9
Other Finance Cost-0
Net Interest Income208
 
Pretax Income (+$)
Operating Income-16,575
Net Interest Income208
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-122,52289,579
EBIT - interestExpense = -16,628
-122,467
-104,602
Interest Expense9
Earnings Before Interest and Taxes (EBIT)-16,619-122,513
Earnings Before Interest and Taxes (EBITDA)-16,618
 
After tax Income (+$)
Income Before Tax-122,522
Tax Provision--17,856
Net Income From Continuing Ops-104,666-104,666
Net Income-104,611
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses16,576
Total Other Income/Expenses Net-106,154-208
 

Technical Analysis of Portage Biotech Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Portage Biotech Inc. The general trend of Portage Biotech Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Portage Biotech Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Portage Biotech Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.34 < 0.45 < 0.45.

The bearish price targets are: 0.1999.

Tweet this
Portage Biotech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Portage Biotech Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Portage Biotech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Portage Biotech Inc. The current macd is -0.08639256.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Portage Biotech Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Portage Biotech Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Portage Biotech Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Portage Biotech Inc Daily Moving Average Convergence/Divergence (MACD) ChartPortage Biotech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Portage Biotech Inc. The current adx is 16.65.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Portage Biotech Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Portage Biotech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Portage Biotech Inc. The current sar is 0.41021827.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Portage Biotech Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Portage Biotech Inc. The current rsi is 30.89. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Portage Biotech Inc Daily Relative Strength Index (RSI) ChartPortage Biotech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Portage Biotech Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Portage Biotech Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Portage Biotech Inc Daily Stochastic Oscillator ChartPortage Biotech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Portage Biotech Inc. The current cci is -89.13473025.

Portage Biotech Inc Daily Commodity Channel Index (CCI) ChartPortage Biotech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Portage Biotech Inc. The current cmo is -42.99261579.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Portage Biotech Inc Daily Chande Momentum Oscillator (CMO) ChartPortage Biotech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Portage Biotech Inc. The current willr is -91.56818182.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Portage Biotech Inc Daily Williams %R ChartPortage Biotech Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Portage Biotech Inc.

Portage Biotech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Portage Biotech Inc. The current atr is 0.095644.

Portage Biotech Inc Daily Average True Range (ATR) ChartPortage Biotech Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Portage Biotech Inc. The current obv is -960,696.

Portage Biotech Inc Daily On-Balance Volume (OBV) ChartPortage Biotech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Portage Biotech Inc. The current mfi is 39.31.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Portage Biotech Inc Daily Money Flow Index (MFI) ChartPortage Biotech Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Portage Biotech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Portage Biotech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Portage Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.889
Ma 20Greater thanMa 500.402
Ma 50Greater thanMa 1000.495
Ma 100Greater thanMa 2000.796
OpenGreater thanClose0.259
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Portage Biotech Inc with someone you think should read this too:
  • Are you bullish or bearish on Portage Biotech Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Portage Biotech Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Portage Biotech Inc

I send you an email if I find something interesting about Portage Biotech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Portage Biotech Inc.

Receive notifications about Portage Biotech Inc in your mailbox!